Thomas Bengtsson

5.2k total citations
111 papers, 2.8k citations indexed

About

Thomas Bengtsson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Bengtsson has authored 111 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 50 papers in Physiology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Bengtsson's work include Asthma and respiratory diseases (49 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (38 papers) and Respiratory and Cough-Related Research (32 papers). Thomas Bengtsson is often cited by papers focused on Asthma and respiratory diseases (49 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (38 papers) and Respiratory and Cough-Related Research (32 papers). Thomas Bengtsson collaborates with scholars based in Sweden, United States and United Kingdom. Thomas Bengtsson's co-authors include Chris Snyder, Reinhard Furrer, Peter J. Bickel, J. G. Anderson, Joseph E. Cavanaugh, Doug Nychka, Viktoría Werkström, Ulf Hindorf, Jonas Pettersson and Paula Persson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Geophysical Research Atmospheres.

In The Last Decade

Thomas Bengtsson

102 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Bengtsson Sweden 28 985 927 494 440 333 111 2.8k
Jinsong Chen China 32 173 0.2× 105 0.1× 282 0.6× 289 0.7× 220 0.7× 223 3.7k
Patrick J. Haley United States 35 273 0.3× 136 0.1× 565 1.1× 425 1.0× 108 0.3× 141 4.0k
Avner Bar‐Hen France 27 146 0.1× 94 0.1× 196 0.4× 201 0.5× 197 0.6× 110 2.2k
Richard H. Jones United States 33 182 0.2× 113 0.1× 333 0.7× 348 0.8× 470 1.4× 147 4.5k
W.J. Wilson United States 40 147 0.1× 443 0.5× 1.4k 2.9× 280 0.6× 88 0.3× 221 5.9k
Johan Segers Belgium 28 681 0.7× 206 0.2× 204 0.4× 1.0k 2.3× 340 1.0× 109 4.4k
Alireza Yazdani United States 23 640 0.6× 250 0.3× 88 0.2× 79 0.2× 248 0.7× 38 3.2k
David Ingram United Kingdom 37 153 0.2× 148 0.2× 444 0.9× 140 0.3× 172 0.5× 261 5.8k
R. Bellotti Italy 33 372 0.4× 224 0.2× 51 0.1× 101 0.2× 809 2.4× 239 3.9k
Tomoyuki Higuchi Japan 28 151 0.2× 100 0.1× 193 0.4× 142 0.3× 502 1.5× 146 4.1k

Countries citing papers authored by Thomas Bengtsson

Since Specialization
Citations

This map shows the geographic impact of Thomas Bengtsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bengtsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bengtsson more than expected).

Fields of papers citing papers by Thomas Bengtsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bengtsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bengtsson. The network helps show where Thomas Bengtsson may publish in the future.

Co-authorship network of co-authors of Thomas Bengtsson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Bengtsson. A scholar is included among the top collaborators of Thomas Bengtsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Bengtsson. Thomas Bengtsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akuthota, Praveen, Njira Lugogo, Peter B. Barker, et al.. (2025). Clinical relevance of CompEx Asthma and impact on disease trajectory: benralizumab effect. ERJ Open Research. 12(1). 486–2025.
2.
3.
4.
5.
Sjöberg, Folke, et al.. (2024). Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin II type 2 receptor agonist. Clinical and Translational Science. 17(2). e13735–e13735. 3 indexed citations
6.
Dransfield, Mark T., Ravi Kalhan, Antonio Anzueto, et al.. (2024). Ensifentrine Added on to LAMA Therapy Improved Lung Function and Reduced Exacerbations in Symptomatic Subjects With Moderate-to-Severe COPD. A6614–A6614. 1 indexed citations
7.
Wang, Xiaoyong, Tarec Christoffer El‐Galaly, Lale Kostakoglu, et al.. (2024). Automated Lugano Metabolic Response Assessment in 18 F-Fluorodeoxyglucose–Avid Non-Hodgkin Lymphoma With Deep Learning on 18 F-Fluorodeoxyglucose–Positron Emission Tomography. Journal of Clinical Oncology. 42(25). 2966–2977. 6 indexed citations
8.
Donohue, James F., et al.. (2023). Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. International Journal of COPD. Volume 18. 1611–1622. 19 indexed citations
9.
10.
11.
Tornling, Göran, Joanna C. Porter, Bryan Williams, et al.. (2021). Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial. EClinicalMedicine. 41. 101152–101152. 30 indexed citations
12.
Rickard, Kathleen, Tara Rheault, & Thomas Bengtsson. (2020). Additional Bronchodilation by Ensifentrine, A Dual PDE3/4 Inhibitor, When Combined with a LAMA/LABA in Patients with Moderate to Severe COPD. A4298–A4298. 4 indexed citations
13.
Bohórquez, Sandra Sanabria, Jan Mařı́k, Annie Ogasawara, et al.. (2019). [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2077–2089. 82 indexed citations
14.
Pettersson, Jonas, Ulf Hindorf, Paula Persson, et al.. (2007). Muscular exercise can cause highly pathological liver function tests in healthy men. British Journal of Clinical Pharmacology. 65(2). 253–259. 249 indexed citations
15.
Furrer, Reinhard & Thomas Bengtsson. (2006). Estimation of high-dimensional prior and posterior covariance matrices in Kalman filter variants. Journal of Multivariate Analysis. 98(2). 227–255. 276 indexed citations
16.
Eliraz, A, Gunnar Johansson, Göran Tornling, et al.. (2005). Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respiratory Medicine. 99(12). 1511–1520. 68 indexed citations
17.
Чучалин, А. Г., et al.. (2004). Formoterol used as needed in patients with intermittent or mild persistent asthma. Respiratory Medicine. 99(4). 461–470. 11 indexed citations
18.
Pauwels, Ruben, M.R. Sears, Mhairi Campbell, et al.. (2003). Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. European Respiratory Journal. 22(5). 787–794. 99 indexed citations
19.
Fishwick, David, Lisa Bradshaw, Richard Beasley, et al.. (2001). Cumulative and Single-dose Design to Assess the Bronchodilator Effects of β2-Agonists in Individuals with Asthma. American Journal of Respiratory and Critical Care Medicine. 163(2). 474–477. 34 indexed citations
20.
Qvarfordt, Ingemar, et al.. (1998). Immunological findings in blood and bronchoalveolar lavage fluid in chronic bronchitis patients with recurrent infectious exacerbations. European Respiratory Journal. 11(1). 46–54. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinsong Chen Breakdown of academic impact, for papers by Patrick J. Haley Breakdown of academic impact, for papers by Avner Bar‐Hen Breakdown of academic impact, for papers by Richard H. Jones Breakdown of academic impact, for papers by W.J. Wilson Breakdown of academic impact, for papers by Johan Segers Breakdown of academic impact, for papers by Alireza Yazdani Breakdown of academic impact, for papers by David Ingram Breakdown of academic impact, for papers by R. Bellotti Breakdown of academic impact, for papers by Tomoyuki Higuchi
Rankless by CCL
2026